STOCK TITAN

Director at Outset Medical (OM) receives 10,667-share stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HACKETT PATRICK T reported acquisition or exercise transactions in this Form 4 filing.

Outset Medical, Inc. director Patrick T. Hackett received a grant of 10,667 shares of common stock as a stock award at a stated price of $0.00 per share. These RSUs will vest 100% on the earlier of the one-year anniversary of the grant date or the company’s next Annual Meeting of Stockholders.

Following this grant, Hackett holds 105,839 shares of Outset Medical common stock directly. He also has indirect ownership of 41,666 shares through the Hackett Family Fund and 83,333 shares through the GST Trust as of the transaction date.

Positive

  • None.

Negative

  • None.
Insider HACKETT PATRICK T
Role null
Type Security Shares Price Value
Grant/Award Common Stock 10,667 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 105,839 shares (Direct, null); Common Stock — 83,333 shares (Indirect, GST Trust)
Footnotes (1)
  1. [object Object]
RSU grant size 10,667 shares Common stock award to director Patrick Hackett
Grant price $0.00 per share Stated price for RSU grant
Direct holdings after grant 105,839 shares Patrick Hackett direct ownership following transaction
Hackett Family Fund holdings 41,666 shares Indirect ownership through Hackett Family Fund
GST Trust holdings 83,333 shares Indirect ownership through GST Trust
RSUs financial
"100% of the shares underlying these RSUs will vest upon the earlier"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Annual Meeting of Stockholders financial
"the date of the Issuer's next Annual Meeting of Stockholders"
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition"
indirect ownership financial
""ownership_type": "indirect", "ownership_code": "I""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HACKETT PATRICK T

(Last)(First)(Middle)
3052 ORCHARD DRIVE

(Street)
SAN JOSE CALIFORNIA 95134

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/04/2026A10,667(1)A$0.0105,839D
Common Stock83,333IGST Trust
Common Stock41,666IHackett Family Fund
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders
By: John L Brottem For: Patrick T Hackett06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Outset Medical (OM) director Patrick Hackett report in this Form 4?

Patrick Hackett reported receiving 10,667 shares of Outset Medical common stock as a stock award. The grant was priced at $0.00 per share and reflects compensation, not an open-market purchase, and increased his directly held stake in the company.

How many Outset Medical (OM) shares does Patrick Hackett hold after this grant?

After the grant, Patrick Hackett directly holds 105,839 shares of Outset Medical common stock. In addition, he has indirect ownership of 41,666 shares through the Hackett Family Fund and 83,333 shares through the GST Trust, all as of the transaction date.

How do the 10,667 granted shares to Patrick Hackett at Outset Medical (OM) vest?

The 10,667 RSUs granted to Patrick Hackett vest 100% on a single future date. Vesting occurs on the earlier of the one-year anniversary of the grant date or the date of Outset Medical’s next Annual Meeting of Stockholders, aligning the award with board service.

Was Patrick Hackett’s Outset Medical (OM) Form 4 transaction a market purchase or sale?

No, the reported transaction was a stock award grant, not a market trade. The Form 4 shows a grant of 10,667 shares at $0.00 per share, categorized as a compensation-related acquisition rather than an open-market buy or sell of existing shares.

What indirect Outset Medical (OM) holdings are reported for Patrick Hackett?

Patrick Hackett reports two indirect holdings in Outset Medical common stock. These include 41,666 shares held through the Hackett Family Fund and 83,333 shares held through the GST Trust, in addition to his directly owned shares reported in the filing.